Featured Article
Biography of Ulrich Krull, HCSC Chair

Ulrich Krull completed his BSc, MSc and PhD (1983) degrees at the University of Toronto. He is appointed as a Professor of Analytical Chemistry at the University of Toronto, and holds the endowed AstraZeneca Chair in Biotechnology. He presently handles the portfolio of Vice-Principal:Research at the University of Toronto Mississauga (UTM).

His professional interests focus in the area of biosensor research, and development of molecular diagnostics technology for biomedical and environmental applications. His research work is exploring the use of nanoscale materials and microfluidics chip technologies to build devices for detection of DNA and RNA targets, and includes nanotechnology for real-time intracellular determination of expression. Some of these device technologies are presently being commercialized, and work by his research team has been fundamental in the launch of 4 start-up companies. Krull is recognized as one of the leading analytical chemists in Canada.

He has over 200 refereed publications, has co-authored more than 60 book chapters, has co-edited 4 books and is an inventor listed on over a dozen patents. He is a Fellow of the Chemical Institute of Canada. He has received both the McBryde Medal, and the Maxxam Award of the Canadian Society for Chemistry (the top awards for analytical chemistry research in Canada). He has been a recipient of the University of Toronto Faculty Excellence Award (top award for research-teaching-service), as well as a Teaching Excellence Award.

Krull has served as the Associate Dean-Sciences, and also Vice-Dean:Graduate Affairs at UTM, Vice-President of the Royal Canadian Institute, and is an editor of Analytica Chimica Acta, a major international journal for analytical chemistry. He serves on a number of Advisory Boards for industry, on Boards for organizations that support acceleration of commercialization opportunities, and is Chair of the Healthy City Stewardship Centre.